A Novel Cell-Penetrating Peptide Derived from Human Eosinophil Cationic Protein

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Fang, Shun lung ^a   Fan, Tan chi ^b   Fu, Hua Wen ^a   Chen, Chien Jung ^a   Hwang, Chi Shin ^a,c   Hung, Ta Jen ^a   Lin, Lih Yuan ^a   Chang, Margaret Dah Tsyr ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; CYSTEINE; EOSINOPHIL CATIONIC PROTEIN; GLYCOSAMINOGLYCAN; HEPARIN BINDING PROTEIN; PEPTIDOMIMETIC AGENT; PROTEOHEPARAN SULFATE; TRYPTOPHAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CHO CELL; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; INTERNALIZATION; INTESTINE VILLUS; LIPID RAFT; NONHUMAN; PEPTIDE ANALYSIS; PINOCYTOSIS; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN TARGETING; PROTEIN TRANSPORT; RAT; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL-PENETRATING PEPTIDES; CHO CELLS; CRICETINAE; CRICETULUS; CYSTEINE; EOSINOPHIL CATIONIC PROTEIN; EPITHELIAL CELLS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; KINETICS; MEMBRANE MICRODOMAINS; MOLECULAR SEQUENCE DATA; PINOCYTOSIS; PROTEIN BINDING; TRYPTOPHAN;

EID: 84874641140     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057318     Document Type: Article

References (51)

1. Kersemans V, Kersemans K, Cornelissen B, (2008) Cell penetrating peptides for in vivo molecular imaging applications. Curr Pharm Des 14: 2415-2447.
2. Bitler BG, Schroeder JA, (2010) Anti-cancer therapies that utilize cell penetrating peptides. Recent Pat Anticancer Drug Discov 5: 99-108.
3. Console S, Marty C, Garcia-Echeverria C, Schwendener R, Ballmer-Hofer K, (2003) Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 278: 35109-35114.
4. Deshayes S, Plenat T, Charnet P, Divita G, Molle G, et al. (2006) Formation of transmembrane ionic channels of primary amphipathic cell-penetrating peptides. Consequences on the mechanism of cell penetration. Biochim Biophys Acta 1758: 1846-1851.
5. Gandhi NS, Mancera RL, (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72: 455-482.
6. Abes R, Arzumanov AA, Moulton HM, Abes S, Ivanova GD, et al. (2007) Cell-penetrating-peptide-based delivery of oligonucleotides: an overview. Biochem Soc Trans 35: 775-779.
7. Letoha T, Keller-Pinter A, Kusz E, Kolozsi C, Bozso Z, et al. (2010) Cell-penetrating peptide exploited syndecans. Biochim Biophys Acta 1798: 2258-2265.
8. Kim WJ, Christensen LV, Jo S, Yockman JW, Jeong JH, et al. (2006) Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol Ther 14: 343-350.
9. Wollack JW, Zeliadt NA, Ochocki JD, Mullen DG, Barany G, et al. (2010) Investigation of the sequence and length dependence for cell-penetrating prenylated peptides. Bioorg Med Chem Lett 20: 161-163.
10. Vives E, Brodin P, Lebleu B, (1997) A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272: 16010-16017.
11. Gautam A, Singh H, Tyagi A, Chaudhary K, Kumar R, et al. (2012) CPPsite: a curated database of cell penetrating peptides. Database (Oxford) 2012: bas015.
12. Xie W, Liu J, Qiu M, Yuan J, Xu A, (2010) Design, synthesis and biological activity of cell-penetrating peptide-modified octreotide analogs. J Pept Sci 16: 105-109.
13. Cardin AD, Weintraub HJ, (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9: 21-32.
14. Christiaens B, Symoens S, Verheyden S, Engelborghs Y, Joliot A, et al. (2002) Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes. Eur J Biochem 269: 2918-2926.
15. Rosenberg HF, (1995) Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity. J Biol Chem 270: 7876-7881.
16. Egesten A, Alumets J, von Mecklenburg C, Palmegren M, Olsson I, (1986) Localization of eosinophil cationic protein, major basic protein, and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique. J Histochem Cytochem 34: 1399-1403.
17. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, et al. (1989) Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 142: 4428-4434.
18. Rosenberg HF, (2008) Eosinophil-derived neurotoxin/RNase 2: connecting the past, the present and the future. Curr Pharm Biotechnol 9: 135-140.
19. Torrent M, Navarro S, Moussaoui M, Nogues MV, Boix E, (2008) Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry 47: 3544-3555.
20. Torrent M, de la Torre BG, Nogues VM, Andreu D, Boix E, (2009) Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem J 421: 425-434.
21. Sanchez D, Moussaoui M, Carreras E, Torrent M, Nogues V, et al. (2011) Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage. Biochimie 93: 331-338.
22. Garcia-Mayoral MF, Moussaoui M, de la Torre BG, Andreu D, Boix E, et al. (2010) NMR structural determinants of eosinophil cationic protein binding to membrane and heparin mimetics. Biophys J 98: 2702-2711.
23. Fan TC, Chang HT, Chen IW, Wang HY, Chang MD, (2007) A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein. Traffic 8: 1778-1795.
24. Chang KC, Lo CW, Fan TC, Chang MD, Shu CW, et al. (2010) TNF-alpha Mediates Eosinophil Cationic Protein-induced Apoptosis in BEAS-2B Cells. BMC Cell Biol 11: 6.
25. Fan TC, Fang SL, Hwang CS, Hsu CY, Lu XA, et al. (2008) Characterization of molecular interactions between eosinophil cationic protein and heparin. J Biol Chem 283: 25468-25474.
26. Lidholt K, Weinke JL, Kiser CS, Lugemwa FN, Bame KJ, et al. (1992) A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci U S A 89: 2267-2271.
27. Esko JD, Stewart TE, Taylor WH, (1985) Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci U S A 82: 3197-3201.
28. Stewart KM, Horton KL, Kelley SO, (2008) Cell-penetrating peptides as delivery vehicles for biology and medicine. Org Biomol Chem 6: 2242-2255.
29. Fotin-Mleczek M, Fischer R, Brock R, (2005) Endocytosis and cationic cell-penetrating peptides-a merger of concepts and methods. Curr Pharm Des 11: 3613-3628.
30. Skerlavaj B, Gennaro R, Bagella L, Merluzzi L, Risso A, et al. (1996) Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J Biol Chem 271: 28375-28381.
31. Risso A, Braidot E, Sordano MC, Vianello A, Macri F, et al. (2002) BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol Cell Biol 22: 1926-1935.
32. Grassel S, Cohen IR, Murdoch AD, Eichstetter I, Iozzo RV, (1995) The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester. Mol Cell Biochem 145: 61-68.
33. David G, (1993) Integral membrane heparan sulfate proteoglycans. FASEB J 7: 1023-1030.
34. Caesar CE, Esbjorner EK, Lincoln P, Norden B, (2006) Membrane interactions of cell-penetrating peptides probed by tryptophan fluorescence and dichroism techniques: correlations of structure to cellular uptake. Biochemistry 45: 7682-7692.
35. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, et al. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97: 13003-13008.
36. Maiolo JR, Ferrer M, Ottinger EA, (2005) Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim Biophys Acta 1712: 161-172.
37. Rydberg HA, Matson M, Amand HL, Esbjorner EK, Norden B (2012) Effects of Tryptophan Content and Backbone Spacing on the Uptake Efficiency of Cell-Penetrating Peptides. Biochemistry.
38. Kamide K, Nakakubo H, Uno S, Fukamizu A, (2010) Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications. Int J Mol Med 25: 41-51.
39. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, et al. (2001) Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276: 5836-5840.
40. Derossi D, Joliot AH, Chassaing G, Prochiantz A, (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269: 10444-10450.
41. Jha D, Mishra R, Gottschalk S, Wiesmuller KH, Ugurbil K, et al. (2011) CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes. Bioconjug Chem 22: 319-328.
42. Zhang W, Smith SO, (2005) Mechanism of penetration of Antp(43-58) into membrane bilayers. Biochemistry 44: 10110-10118.
43. Ram N, Aroui S, Jaumain E, Bichraoui H, Mabrouk K, et al. (2008) Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine. J Biol Chem 283: 24274-24284.
44. Patel LN, Zaro JL, Shen WC, (2007) Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res 24: 1977-1992.
45. Ziegler A, (2008) Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans. Adv Drug Deliv Rev 60: 580-597.
46. Vives E, Schmidt J, Pelegrin A, (2008) Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 1786: 126-138.
47. Sarko D, Beijer B, Garcia Boy R, Nothelfer EM, Leotta K, et al. (2010) The pharmacokinetics of cell-penetrating peptides. Mol Pharm 7: 2224-2231.
48. Beer AJ, Haubner R, Sarbia M, Goebel M, Luderschmidt S, et al. (2006) Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res 12: 3942-3949.
49. Nishimura S, Takahashi S, Kamikatahira H, Kuroki Y, Jaalouk DE, et al. (2008) Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells. J Biol Chem 283: 11752-11762.
50. Miyamoto MM, Koop BF, Slightom JL, Goodman M, Tennant MR, (1988) Molecular systematics of higher primates: genealogical relations and classification. Proc Natl Acad Sci U S A 85: 7627-7631.
51. Tjelle TE, Brech A, Juvet LK, Griffiths G, Berg T, (1996) Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation. J Cell Sci 109 (Pt 12): 2905-2914.